Added to YB: 2017-09-01
Pitch date: 2017-09-01
PTGX:US [bullish]
Protagonist Therapeutics, Inc.
+388.79%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.
Market Cap
$5.4B
Pitch Price
$21.05
Price Target
N/A
Dividend
N/A
EV/EBITDA
-31.16
P/E
-42.49
EV/Sales
104.52
Sector
Biotechnology
Category
N/A
Show full summary:
PROTAGONIST THERAPEUTICS INC COM PTGX:US
A summary for this pitch has not been created yet.
Read full article (0 min)